Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed SEC probe update

This article was originally published in The Gray Sheet

Executive Summary

Securities and Exchange Commission staffers recommend halting the investigation of Inamed's disclosures for its silicone gel-filled breast implants, after advising that no enforcement action be taken, the firm reports in a Nov. 9 10-K filing. The firm has repeatedly claimed it is in compliance with federal securities laws since the probe began in February (1"The Gray Sheet" March 21, 2005, In Brief)...
Advertisement

Related Content

SEC investigation targets Inamed
Advertisement
UsernamePublicRestriction

Register

MT022901

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel